GenPrime

GenPrime is a healthcare organization focused on delivering comprehensive fertility solutions through advanced clinics and diagnostic tools. They cater to diverse clients facing various fertility challenges, providing inclusive and tailored care. Founded in 1997 and headquartered in Spokane, US, GenPrime specializes in fertility treatments, offering innovative services to assist individuals and couples. The company has completed 2 deals, with the most recent funding round occurring on January 10, 2013, raising USD 0.

16 mn. The CEO, Buck Somes, leads the firm which has consistently focused on reproductive health. GenPrime specializes in providing comprehensive fertility solutions through a network of state-of-the-art clinics and advanced diagnostic tools. Their core offerings include In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), fertility preservation, preimplantation genetic testing, and third-party reproduction services such as egg and sperm donation.

These services are designed to assist individuals and couples facing various fertility challenges, including those seeking to preserve fertility before cancer treatment, address genetic conditions, or navigate delayed parenthood. GenPrime serves a diverse client base that includes individuals across different demographics, including men, women, LGBTQ+ individuals, and single parents, ensuring inclusive care tailored to each unique journey. Their services are available across multiple geographical markets, including Thailand, Malaysia, Singapore, and the United States, among others. GenPrime generates revenue through a direct-to-consumer model, where clients pay for fertility services on a per-treatment basis.

This transactional structure includes pricing for services such as IVF cycles, egg freezing procedures, and advanced fertility testing, with clients typically engaging in one-off or multi-cycle treatment plans based on their needs. The company’s flagship offerings, including IVF and fertility preservation, form the majority of the revenue stream, reflecting a growing demand for advanced reproductive health services. Client payments are processed at the initiation of treatment or through structured payment plans that may encompass multiple services over time, establishing GenPrime's financial framework on facilitating access to essential fertility treatments while supporting clients throughout their family-building journey. In January 2013, GenPrime raised USD 0.

16 mn in a funding round aimed at supporting upcoming initiatives. The company plans to expand its market presence, targeting new regions to increase access to its fertility services. Specific markets for expansion include Southeast Asia, with a focus on solidifying its operations in Malaysia and Thailand by 2024. The recent funding will be utilized to enhance product offerings and improve clinic facilities, ensuring that GenPrime continues to meet the evolving needs of its clients.